Heparin- and basic fibroblast growth factor-incorporated stent: A new promising method for myocardial revascularization

Journal of Surgical Research

Volumn 164, Issue 2, 2010, Pages 204-213

  Liu, Xiao Cheng ^a,b,c   Zhao, Jian ^a,b   Wang, Ying ^a,b   Liu, Tian Jun ^d   Lü, Feng ^d   He, Guo Wei ^a,c,e,f  

^a TEDA INTERNATIONAL CARDIOVASCULAR HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c NANKAI UNIVERSITY   (China)

^d INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

angiogenesis; biomaterials; coronary artery disease; myocardial infarction; revascularization; stents

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; INTERLEUKIN 1BETA; KI 67 ANTIGEN; MESSENGER RNA; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; MINIPIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STENT;

ANIMALS; DRUG-ELUTING STENTS; ECHOCARDIOGRAPHY; ENDOCARDIUM; EQUIPMENT DESIGN; FIBROBLAST GROWTH FACTOR 2; HEPARIN; INTERLEUKIN-1BETA; KI-67 ANTIGEN; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL REVASCULARIZATION; PERICARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; SWINE, MINIATURE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT; VON WILLEBRAND FACTOR;

EID: 78449280228     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.05.005     Document Type: Article

References (33)

1. Z.S. Jiang, R.R. Padua, and H. Ju Acute protection of ischemic heart by FGF-2: Involvement of FGF-2 receptors and protein kinase C Am J Physiol Heart Circ Physiol 282 2002 1071
2. A. Karsan, E. Yee, and G.G. Poirier Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms Am J Pathol 151 1997 1775
3. M. Simons, B.H. Annex, and R.J. Laham Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial Circulation 105 2002 788
4. G.F. Whalen, Y. Shing, and J. Folkman The fate of intravenously administered bFGF and the effect of heparin Growth Factors 1 1989 157
5. R.J. Laham, M. Post, and M. Rezaee Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: Myocardial and tissue distribution Drug Metab Dispos 33 2005 1101
6. F.W. Sellke, R.J. Laham, and E.R. Edelman Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results Ann Thorac Surg 65 1998 1540
7. M. Yamamoto, Y. Ikada, and Y. Tabata Controlled release of growth factors based on biodegradation of gelatin hydrogel J Biomater Sci Polym Ed 12 2001 77
8. S.T. Nillesen, P.J. Geutjes, and R. Wismans Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF Biomaterials 28 2007 1123
9. J. Cinca, M. Warren, and A. Carreño Changes in myocardial electrical impedance induced by coronary artery occlusion in pigs with and without preconditioning: Correlation with local ST-segment potential and ventricular arrhythmias Circulation 96 1997 3079
10. H. Sun, L. Mei, and C. Song The in vivo degradation, absorption and excretion of PCL-based implant Biomaterials 27 2006 1735
11. Z. Ma, W. He, T. Yong, and S. Ramakrishna Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation Tissue Eng 11 2005 1149
12. H.J. Chung, H.K. Kim, and J.J. Yoon Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery Pharm Res 23 2006 1835
13. O. Jeon, S.W. Kang, and H.W. Lim Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co- glycolide) nanospheres and fibrin gel Biomaterials 27 2006 1598
14. D. Gospodarowicz, and J. Cheng Heparin protects basic and acidic FGF from inactivation J Cell Physiol 128 1986 475
15. B. Schumacher, P. Pecher, and B.U. von Specht Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease Circulation 97 1998 645
16. E.R. Edelman, M.A. Nugent, and M.J. Karnovsky Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition Proc Natl Acad Sci USA 90 1993 1513
17. M.A. Rajanayagam, M. Shou, and V. Thirumurti Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs J Am Coll Cardiol 35 2000 519
18. G. von Degenfeld, P. Raake, and C. Kupatt Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia J Am Coll Cardio 42 2003 1120
19. R. Laham, M. Rezaee, and M. Post Intrapericardial administration of basic fibroblast growth factor: Myocardial and tissue distribution and comparison with intracoronary and intravenous administration Catheter Cardiovasc Intervent 58 2003 375
20. P. Pecher, and B.A. Schumacher Angiogenesis in ischemic human myocardium: Clinical results after 3 years Ann Thorac Surg 69 2000 1414
21. G. Ma, C. Song, and H. Sun A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs Contraception 74 2006 141 147
22. A.E. Elcin, and Y.M. Elcin Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge Tissue Eng 12 2006 959
23. M.T. Aguado, and P.H. Lambert Controlled-release vaccines - biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles Immunobiol 184 1992 113
24. W.L. Webber, F. Lago, and C. Thanos Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline J Biomed Mater Res 41 1998 18
25. O. Saksela, D. Moscatelli, and A. Sommer Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation J Cell Biol 107 1988 743
26. S.I. Zittermann, and A.C. Issekutz Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation J Leukoc Biol 80 2006 247
27. M. Anghelina, P. Krishnan, and L. Moldovan Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: Conversion of cell columns into fibrovascular bundles Am J Pathol 168 2006 529
28. M.H. Liu, H. Jin, and H.S. Floten Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery Ann Thorac Surg 73 2002 819
29. N. Muraoka, L. Shum, and S. Fukumoto Transforming growth factor-beta3 promotes mesenchymal cell proliferation and angiogenesis mediated by the enhancement of cyclin D1, Flk-1, and CD31 gene expression during CL/Fr mouse lip fusion Birth Defects Res A Clin Mol Teratol 73 2005 956
30. D.J. Mountain, M. Singh, and B. Menon Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: Role of PKCα/β1 and MAPKs Am J Physiol Cell Physiol 292 2007 C867
31. D.F. Lazarous, M. Shou, and J.A. Stiber Pharmacodynamics of basic fibroblast growth factor: Route of administration determines myocardial and systemic distribution Cardiovasc Res 36 1997 78
32. Y. Uchida, A. Yanagisawa-Miwa, and F. Nakamura Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study Am Heart J 130 1995 1182
33. C.J. Teng, J. Luo, and R.J. Chiu Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: Implications for cellular cardiomyoplasty J Thorac Cardiovasc Surg 132 2006 628